Uncategorised

The American Thoracic Society (ATS) annually stages the world's largest gathering of respiratory health professionals.  ATS 2022 is being held 15-18 May in San Francisco, with 4DMedical prominent in the program, scientific paper presentations and in the exhibit hall. Follow our social media to stay in...

General practitioners and respiratory specialists in south-eastern Melbourne will soon be able to order highly visual reports of patients’ lung function based upon four-dimensional scans, following successful completion of pilot programs by 4DMedical in collaboration with I-MED Radiology Network, Australia’s largest diagnostic imaging provider. Commencing...

Australia-wide access to 4DMedical’s cloud-based XV Technology, enabling unprecedented understanding of lung motion and airflow, is moving closer to reality through a partnership announced today with leading integration provider, Kailo Medical. 4DMedical’s XV Technology Lung Ventilation Analysis Software (XV LVAS) provides highly detailed maps of...

Lung transplants offer people afflicted with incurable respiratory disease the prospect of a better quality of life – XV Technology optimises success of expensive, resource-intensive procedures. Alfred Health-based ‘FIT’ Study announced today involves 40 patients affected by conditions including interstitial lung disease, severe COPD, pulmonary...

Clinical trials are a core pillar of 4DMedical’s commercialisation strategy. The iconic Johns Hopkins Medical Center exemplifies the quality of our partners evolving scientific investigation into case application. Achieving ‘first imaging’ status in Baltimore represents further progress against strategy. See the status of our clinical trials...

4DMedical’s intensive clinical trials program continues to progress against strategy with the announcement of our Cleveland Clinic-based activity reaching ‘first imaging’ status, despite the ongoing COVID-19 challenge. Our commitment to this ongoing program of clinical trials grows a body of scientific evidence driving market uptake. See...

VIDEO:  XV Technology's application to monitoring the post-COVID condition shown on Fox, NBC, CBS and ABC network news channels across America. [vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="grid" angled_section="no" text_align="left" background_image_as_pattern="without_pattern" z_index=""][vc_column][vc_column_text]"Doctors in California are using four-dimensional lung scans...

The world’s first four-dimensional visual insight into the residual effects of COVID-19 or ‘long COVID’ providing an unprecedented ability for patients, clinicians and researchers to understand the ongoing impact of this disease has been obtained using 4DMedical’s unique XV Technology. 4DMedical today confirmed that COVID-afflicted...

Medtech innovator 4DMedical announces Phase Two of Australian clinical pilot program with I-MED Radiology Network Following successful completion of a comprehensive clinical pilot program conducted in collaboration with I-MED Radiology, Australia’s largest diagnostic imaging network, 4DMedical announces plans for a Phase Two program commencing immediately. The Phase...